These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 31098422)

  • 21. Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy.
    Siddiqui MM; Rais-Bahrami S; Truong H; Stamatakis L; Vourganti S; Nix J; Hoang AN; Walton-Diaz A; Shuch B; Weintraub M; Kruecker J; Amalou H; Turkbey B; Merino MJ; Choyke PL; Wood BJ; Pinto PA
    Eur Urol; 2013 Nov; 64(5):713-719. PubMed ID: 23787357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnetic Resonance Imaging-guided In-bore and Magnetic Resonance Imaging-transrectal Ultrasound Fusion Targeted Prostate Biopsies: An Adjusted Comparison of Clinically Significant Prostate Cancer Detection Rate.
    Costa DN; Goldberg K; Leon AD; Lotan Y; Xi Y; Aziz M; Freifeld Y; Margulis V; Raj G; Roehrborn CG; Hornberger B; Desai N; Bagrodia A; Francis F; Pedrosa I; Cadeddu JA
    Eur Urol Oncol; 2019 Jul; 2(4):397-404. PubMed ID: 31277776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiparametric ultrasound-targeted biopsy compares favorably to multiparametric MRI-transrectal ultrasound fusion-targeted biopsy on initial biopsy of men at risk for prostate cancer.
    Fulgham PF
    World J Urol; 2018 May; 36(5):713-718. PubMed ID: 29368230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Initial Experience with Transrectal Magnetic Resonance Imaging Cognitive Guided Micro-Ultrasound Biopsies versus Established Transperineal Robotic Ultrasound Magnetic Resonance Imaging Fusion Biopsies for Prostate Cancer.
    Claros OR; Tourinho-Barbosa RR; Fregeville A; Gallardo AC; Muttin F; Carneiro A; Stabile A; Moschini M; Macek P; Cathala N; Mombet A; Sanchez-Salas R; Cathelineau X
    J Urol; 2020 May; 203(5):918-925. PubMed ID: 31821099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of 3-Tesla multiparametric magnetic resonance imaging and targeted biopsy for improved risk stratification in patients considered for active surveillance.
    Pessoa RR; Viana PC; Mattedi RL; Guglielmetti GB; Cordeiro MD; Coelho RF; Nahas WC; Srougi M
    BJU Int; 2017 Apr; 119(4):535-542. PubMed ID: 27500389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MRI/US fusion-guided prostate biopsy allows for equivalent cancer detection with significantly fewer needle cores in biopsy-naive men.
    Yarlagadda VK; Lai WS; Gordetsky JB; Porter KK; Nix JW; Thomas JV; Rais-Bahrami S
    Diagn Interv Radiol; 2018; 24(3):115-120. PubMed ID: 29770762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can MRI/TRUS fusion targeted biopsy replace saturation prostate biopsy in the re-evaluation of men in active surveillance?
    Pepe P; Garufi A; Priolo G; Pennisi M
    World J Urol; 2016 Sep; 34(9):1249-53. PubMed ID: 26699628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted prostate biopsy using a cognitive fusion of multiparametric magnetic resonance imaging and transrectal ultrasound in patients with previously negative systematic biopsies and non-suspicious digital rectal exam.
    Kuliš T; Zekulić T; Alduk AM; Lušić M; Bulimbašić S; Ferenčak V; Mokos I; Hudolin T; Kaštelan Ž
    Croat Med J; 2020 Feb; 61(1):49-54. PubMed ID: 32118378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive MRI-TRUS fusion-targeted prostate biopsy according to PI-RADS classification in patients with prior negative systematic biopsy results.
    Lai WJ; Wang HK; Liu HT; Park BK; Shen SH; Lin TP; Chung HJ; Huang YH; Chang YH
    J Chin Med Assoc; 2016 Nov; 79(11):618-624. PubMed ID: 27567440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Not All Multiparametric Magnetic Resonance Imaging-targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection of Clinically Significant Prostate Cancer.
    Stabile A; Dell'Oglio P; Gandaglia G; Fossati N; Brembilla G; Cristel G; Dehò F; Scattoni V; Maga T; Losa A; Gaboardi F; Cardone G; Esposito A; De Cobelli F; Del Maschio A; Montorsi F; Briganti A
    Eur Urol Oncol; 2018 Jun; 1(2):120-128. PubMed ID: 31100235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen.
    Radtke JP; Schwab C; Wolf MB; Freitag MT; Alt CD; Kesch C; Popeneciu IV; Huettenbrink C; Gasch C; Klein T; Bonekamp D; Duensing S; Roth W; Schueler S; Stock C; Schlemmer HP; Roethke M; Hohenfellner M; Hadaschik BA
    Eur Urol; 2016 Nov; 70(5):846-853. PubMed ID: 26810346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging and Fusion Guided Targeted Biopsy Evaluated by Transperineal Template Saturation Prostate Biopsy for the Detection and Characterization of Prostate Cancer.
    Mortezavi A; Märzendorfer O; Donati OF; Rizzi G; Rupp NJ; Wettstein MS; Gross O; Sulser T; Hermanns T; Eberli D
    J Urol; 2018 Aug; 200(2):309-318. PubMed ID: 29474846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of free-hand transperineal targeted prostate biopsy using multiparametric magnetic resonance imaging-transrectal ultrasound fusion in Chinese men with prior negative biopsy and elevated prostate-specific antigen.
    Lian H; Zhuang J; Wang W; Zhang B; Shi J; Li D; Fu Y; Jiang X; Zhou W; Guo H
    BMC Urol; 2017 Jul; 17(1):52. PubMed ID: 28679370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An initial negative round of targeted biopsies in men with highly suspicious multiparametric magnetic resonance findings does not exclude clinically significant prostate cancer-Preliminary experience.
    Costa DN; Kay FU; Pedrosa I; Kolski L; Lotan Y; Roehrborn CG; Hornberger B; Xi Y; Francis F; Rofsky NM
    Urol Oncol; 2017 Apr; 35(4):149.e15-149.e21. PubMed ID: 27939349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving detection of clinically significant prostate cancer: magnetic resonance imaging/transrectal ultrasound fusion guided prostate biopsy.
    Rastinehad AR; Turkbey B; Salami SS; Yaskiv O; George AK; Fakhoury M; Beecher K; Vira MA; Kavoussi LR; Siegel DN; Villani R; Ben-Levi E
    J Urol; 2014 Jun; 191(6):1749-54. PubMed ID: 24333515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetic resonance imaging-transrectal ultrasound image fusion guidance of prostate biopsies: current status, challenges and future perspectives.
    Boesen L
    Scand J Urol; 2019; 53(2-3):89-96. PubMed ID: 31006323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are Magnetic Resonance Imaging-Transrectal Ultrasound Guided Targeted Biopsies Noninferior to Transrectal Ultrasound Guided Systematic Biopsies for the Detection of Prostate Cancer?
    Delongchamps NB; Portalez D; Bruguière E; Rouvière O; Malavaud B; Mozer P; Fiard G; Cornud F;
    J Urol; 2016 Oct; 196(4):1069-75. PubMed ID: 27079582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accuracy of Magnetic Resonance Imaging/Ultrasound Fusion Targeted Biopsies to Diagnose Clinically Significant Prostate Cancer in Enlarged Compared to Smaller Prostates.
    de Gorski A; Rouprêt M; Peyronnet B; Le Cossec C; Granger B; Comperat E; Cussenot O; Renard-Penna R; Mozer P
    J Urol; 2015 Sep; 194(3):669-73. PubMed ID: 25784374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiparametric MRI-ultrasonography software fusion prostate biopsy: initial results using a stereotactic robotic-assisted transperineal prostate biopsy platform comparing systematic vs targeted biopsy.
    Lee AYM; Yang XY; Lee HJ; Law YM; Huang HH; Lau WKO; Lee LS; Ho HSS; Tay KJ; Cheng CWS; Yuen JSP; Chen K
    BJU Int; 2020 Nov; 126(5):568-576. PubMed ID: 32438463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic and MRI-Cognitive Targeted Transperineal Prostate Biopsy Accuracy in Detecting Clinically Significant Prostate Cancer after Previous Negative Biopsy and Persisting Suspicion of Malignancy.
    Vėželis A; Platkevičius G; Kinčius M; Gumbys L; Naruševičiūtė I; Briedienė R; Petroška D; Ulys A; Jankevičius F
    Medicina (Kaunas); 2021 Jan; 57(1):. PubMed ID: 33435132
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.